Literature DB >> 18045818

A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy.

Masaru Kinomura1, Hitoshi Sugiyama, Takao Saito, Akira Matsunaga, Ken-ei Sada, Motoko Kanzaki, Yuki Takazawa, Yohei Maeshima, Hiroyuki Yanai, Hirofumi Makino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18045818     DOI： 10.1093/ndt/gfm675

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  15 in total

1.  Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation.

Authors:  Ryosuke Usui; Masaki Takahashi; Kosaku Nitta; Minako Koike
Journal:  CEN Case Rep       Date:  2016-03-04

2.  Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.

Authors:  Hiroko Hamatani; Keiju Hiromura; Keiko Kobatake; Hiroaki Yoshida; Satsuki Kobayashi; Naohiro Yoneda; Ken Kayakabe; Takayuki Matsumoto; Takashi Kuroiwa; Kazue Ueki; Yoshihisa Nojima
Journal:  Clin Exp Nephrol       Date:  2010-09-15       Impact factor: 2.801

3.  Lipoprotein Glomerulopathy, First Case Report from Canada.

Authors:  Julie Anne Ting; Susanna A McRae; Daniel Schwartz; Sean J Barbour; Maziar Riazy
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-06-21

4.  Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.

Authors:  Akira Matsunaga; Masayuki Furuyama; Taeko Hashimoto; Kentaro Toyoda; Daisuke Ogino; Kiyoshi Hayasaka
Journal:  Clin Exp Nephrol       Date:  2009-07-15       Impact factor: 2.801

Review 5.  Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.

Authors:  Akira Matsunaga; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2014-02-26       Impact factor: 2.801

Review 6.  A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.

Authors:  Efstratios Stratikos; Angeliki Chroni
Journal:  Clin Exp Nephrol       Date:  2013-10-23       Impact factor: 2.801

7.  Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature.

Authors:  Kunio Kawanishi; Anri Sawada; Ayami Ochi; Takahito Moriyama; Michihiro Mitobe; Toshio Mochizuki; Kazuho Honda; Hideaki Oda; Toshio Nishikawa; Kosaku Nitta
Journal:  Case Rep Nephrol Urol       Date:  2013-11-28

8.  Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy.

Authors:  Satoshi Takasaki; Kunihiko Maeda; Kensuke Joh; Shu Yamakage; Sachiko Fukase; Toshiyuki Takahashi; Masayuki Suzuki; Akira Matsunaga; Takao Saito
Journal:  Case Rep Nephrol Dial       Date:  2015-12-15

9.  Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2.

Authors:  Megumu Fukunaga; Kiyotaka Nagahama; Michiko Aoki; Akira Shimizu; Shigeo Hara; Akira Matsunaga; Eri Muso; Takao Saito
Journal:  Case Rep Nephrol Dial       Date:  2018-03-20

10.  The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.

Authors:  Hongyan Wu; Yuan Yang; Zhangxue Hu
Journal:  J Atheroscler Thromb       Date:  2018-02-02       Impact factor: 4.928
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.